Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients (ZORO)
NCT00196846 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 62
Last updated 2010-06-14
Summary
Study done in young breast cancer patients to prevent chemotherapy induced ovarian failure
Conditions
Interventions
- DRUG
-
Goserelin
Sponsors & Collaborators
-
GBG Forschungs GmbH
lead OTHER
Principal Investigators
-
Bernd Gerber, MD · Rostock Universität, Universitätsfrauenklinik
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-03-31
- Primary Completion
- 2008-12-31
- Completion
- 2010-03-31
Countries
- Germany
Study Locations
More Related Trials
-
Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients with Breast Cancer
NCT03936933 ·Status: TERMINATED ·Phase: PHASE3
-
Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer
NCT00429403 ·Status: TERMINATED ·Phase: PHASE3
-
Effects of GnRHa on Ovarian Function Against Chemotherapy-induced-gonadotoxicity
NCT02518191 ·Status: COMPLETED ·Phase: PHASE3
-
Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With Chemotherapy
NCT00888082 ·Status: WITHDRAWN ·Phase: PHASE3
-
Gonadotropin-Releasing Hormone Agonist for the Preservation of Ovarian Function During Chemotherapy in Premenopausal Breast Cancer
NCT02483767 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Breast Cancer Prevention by Letrozole in High Risk Women
NCT00579826 ·Status: COMPLETED ·Phase: PHASE2
-
Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer
NCT01368263 ·Status: TERMINATED ·Phase: PHASE2
-
Protocol for Women at Increased Risk of Developing Breast Cancer
NCT00291135 ·Status: COMPLETED ·Phase: PHASE2
-
Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer
NCT00090844 ·Status: TERMINATED ·Phase: PHASE2
-
Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer
NCT00031850 ·Status: COMPLETED ·Phase: NA
-
Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid
NCT00295646 ·Status: COMPLETED ·Phase: PHASE3
-
Letrozole in Preventing Breast Cancer in Postmenopausal Women
NCT00090857 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women
NCT00237133 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients
NCT00309478 ·Status: COMPLETED ·Phase: PHASE3
-
Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea
NCT02132390 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast Cancer
NCT00330317 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Role of the Addition of Ovarian Function Suppression (OFS) to Tamoxifen in Young Women
NCT00912548 ·Status: UNKNOWN ·Phase: PHASE3
-
Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial
NCT07158021 ·Status: RECRUITING ·Phase: PHASE2
-
Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast Cancer
NCT03747042 ·Status: COMPLETED ·Phase: PHASE2
-
Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer
NCT00498901 ·Status: TERMINATED ·Phase: PHASE2
-
Assessment of Endometrial Changes in Postmenopausal Women With Breast Cancer in Adjuvant Treatment With Anastrozole
NCT00623519 ·Status: COMPLETED
-
Goserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBC
NCT00532272 ·Status: COMPLETED ·Phase: PHASE2
-
Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery
NCT00651976 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer
NCT01077453 ·Status: COMPLETED ·Phase: PHASE1
-
Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer
NCT00237211 ·Status: COMPLETED ·Phase: PHASE2